Phase II study of bevacizumab in combination with trastuzumab and capecitabine as first-line treatment for HER-2-positive locally recurrent or metastatic breast cancer
- Martín, M.
- Makhson, A.
- Gligorov, J.
- Lichinitser, M.
- Lluch, A.
- Semiglazov, V.
- Scotto, N.
- Mitchell, L.
- Tjulandin, S.
ISSN: 1083-7159, 1549-490X
Datum der Publikation: 2012
Ausgabe: 17
Nummer: 4
Seiten: 469-475
Art: Artikel